14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $8.74 $12.25 Wednesday, 1st May 2024 PHAT stock ended at $9.26. This is 2.55% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 6.36% from a day low at $8.96 to a day high of $9.53.
90 days $6.07 $12.25
52 weeks $6.07 $17.00

Historical Phathom Pharmaceuticals, Inc. prices

Date Open High Low Close Volume
Jan 12, 2024 $7.78 $8.01 $7.49 $7.56 276 738
Jan 11, 2024 $7.99 $8.03 $7.64 $7.68 448 100
Jan 10, 2024 $8.27 $8.56 $7.87 $8.09 841 953
Jan 09, 2024 $8.91 $8.95 $8.25 $8.33 915 217
Jan 08, 2024 $8.93 $8.98 $8.38 $8.80 811 600
Jan 05, 2024 $9.36 $9.48 $8.74 $8.78 595 728
Jan 04, 2024 $9.10 $9.30 $9.00 $9.00 347 367
Jan 03, 2024 $9.18 $9.24 $8.97 $9.10 316 591
Jan 02, 2024 $8.96 $9.59 $8.96 $9.17 238 618
Dec 29, 2023 $9.12 $9.26 $8.93 $9.13 373 233
Dec 28, 2023 $9.24 $9.32 $9.10 $9.14 199 967
Dec 27, 2023 $9.29 $9.40 $8.99 $9.26 297 334
Dec 26, 2023 $9.09 $9.30 $8.94 $9.20 309 050
Dec 22, 2023 $9.09 $9.20 $8.95 $9.01 369 923
Dec 21, 2023 $8.32 $9.00 $8.32 $8.98 396 641
Dec 20, 2023 $8.80 $8.95 $8.14 $8.21 294 516
Dec 19, 2023 $8.28 $8.79 $8.21 $8.74 555 966
Dec 18, 2023 $8.72 $8.72 $8.08 $8.13 342 812
Dec 15, 2023 $9.03 $9.27 $8.67 $8.72 677 319
Dec 14, 2023 $8.30 $9.32 $8.26 $8.93 723 774
Dec 13, 2023 $7.80 $8.31 $7.60 $8.27 359 324
Dec 12, 2023 $7.94 $8.04 $7.76 $7.96 418 813
Dec 11, 2023 $8.42 $8.43 $7.90 $8.11 296 702
Dec 08, 2023 $8.24 $8.78 $8.24 $8.43 349 595
Dec 07, 2023 $8.33 $8.43 $8.02 $8.26 944 551
Click to get the best stock tips daily for free!

About Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals. Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal re... PHAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT